We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+4.36%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$49.1M
(-11%)
Cap. Flow
-$51.9M
Cap. Flow
% of AUM
-12.95%
Top 10 Holdings %
Top 10 Hldgs %
77.61%
Holding
82
New
5
Increased
1
Reduced
3
Closed
2
Avg Time Held
2.6
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immix Biopharma
IMMX
|
+$3.29M |
| 2 |
Cue Biopharma
CUE
|
+$2.35M |
| 3 |
Modular Medical
MODD
|
+$1.25M |
| 4 |
Ideal Power
IPWR
|
+$1.2M |
| 5 |
Talkspace
TALK
|
+$680K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brunswick
BC
|
+$48.4M |
| 2 |
Linde
LIN
|
+$11M |
| 3 |
bluebird bio
BLUE
|
+$1.87M |
| 4 |
SLGCW
SomaLogic, Inc. Warrant
SLGCW
|
+$1.68K |
| 5 |
FAZEW
FaZe Holdings Inc. Warrant
FAZEW
|
+$323 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.85% |
| 2 | Healthcare | 21.24% |
| 3 | Industrials | 16.95% |
| 4 | Materials | 10.55% |
| 5 | Consumer Discretionary | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
SPDR Gold Trust
GLD
$141B
| $97.7M | 24.38% |
475,000
| – | – |
2019 Q4
17 quarters
|
|
|
2
Linde
LIN
$229B
| $42.3M | 10.55% |
91,064
-25,500
| -22% | -$11M |
2019 Q4
17 quarters
|
|
|
3
Brunswick
BC
$4.18B
| $41M | 10.23% |
425,000
-550,636
| -56% | -$48.4M |
2020 Q1
16 quarters
|
|
4
INVE Technologies, Inc. Common Stock
INVE
$55.3M
| $22.8M | 5.7% |
2,884,495
| – | – |
2019 Q4
17 quarters
|
|
5
DELISTED
Paragon 28, Inc.
FNA
| $21.8M | 5.43% |
1,763,339
| – | – |
2023 Q2
3 quarters
|
|
6
GPGI Inc
GPGI
$3.59B
| $21.7M | 5.41% |
3,609,050
| – | – |
2022 Q1
8 quarters
|
|
7
DELISTED
Intevac Inc
IVAC
| $19.3M | 4.83% |
5,039,023
| – | – |
2019 Q4
17 quarters
|
|
8
S&P Global
SPGI
$123B
| $17M | 4.25% |
40,000
| – | – |
2019 Q4
17 quarters
|
|
9
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $16.9M | 4.22% |
1,872,463
| – | – |
2020 Q1
16 quarters
|
|
10
Blackstone
BX
$84.6B
| $10.5M | 2.62% |
80,000
| – | – |
2019 Q4
17 quarters
|
|
11
MDxHealth
MDXH
$58.1M
| $10M | 2.51% |
3,878,333
| – | – |
2021 Q4
9 quarters
|
|
12
Insmed
INSM
$21.7B
| $8.82M | 2.2% |
325,000
| – | – |
2023 Q1
4 quarters
|
|
13
Intellicheck
IDN
$45.6M
| $7.22M | 1.8% |
2,073,583
| – | – |
2019 Q4
17 quarters
|
|
14
JPMorgan Chase
JPM
$887B
| $6.01M | 1.5% |
30,000
| – | – |
2019 Q4
17 quarters
|
|
15
DELISTED
OptiNose
OPTN
| $5.91M | 1.47% |
269,675
| – | – |
2021 Q4
9 quarters
|
|
16
American Express
AXP
$208B
| $5.69M | 1.42% |
25,000
| – | – |
2019 Q4
17 quarters
|
|
17
Duos Technologies
DUOT
$167M
| $5.57M | 1.39% |
1,283,162
| – | – |
2020 Q1
16 quarters
|
|
|
18
Cue Biopharma
CUE
$132M
| $5.21M | 1.3% |
91,834
+33,333
| +57% | +$2.35M |
2019 Q4
17 quarters
|
|
19
ProKidney
PROK
$307M
| $3.28M | 0.82% |
2,000,000
| – | – |
2022 Q3
6 quarters
|
|
20
Televisa
TV
$1.28B
| $3.2M | 0.8% |
1,000,000
| – | – |
2021 Q2
11 quarters
|
|
|
21
Immix Biopharma
IMMX
$727M
| $2.61M | 0.65% |
+850,000
| New | +$3.29M |
2024 Q1
0 quarters
|
|
22
Milestone Pharmaceuticals
MIST
$96.5M
| $2.37M | 0.59% |
1,326,085
| – | – |
2021 Q4
9 quarters
|
|
23
LiqTech
LIQT
$11.9M
| $1.72M | 0.43% |
557,110
| – | – |
2020 Q1
16 quarters
|
|
24
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.64M | 0.41% |
55,216
| – | – |
2019 Q4
17 quarters
|
|
25
Barfresh Food Group
BRFH
$11M
| $1.38M | 0.35% |
1,153,915
| – | – |
2022 Q1
8 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q1 2024 Portfolio in Review
As of Q1 2024, Bleichroeder LP held 82 positions worth $401M, down 11% from $450M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Bleichroeder LP withdrew a net $51.9M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Warrant, an estimated $1.68K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Bleichroeder LP opened a new position in Immix Biopharma worth $2.61M.
- Bleichroeder LP's largest Q1 2024 buy was Immix Biopharma: 850,000 shares worth $2.61M.
- Bleichroeder LP added most to Cue Biopharma in Q1 2024, an estimated $2.35M increase.
- Bleichroeder LP's biggest Q1 2024 reduction was Brunswick, cutting an estimated $48.4M.
- Bleichroeder LP fully exited SomaLogic, Inc. Warrant in Q1 2024, selling an estimated $1.68K.
- Bleichroeder LP's ten largest holdings make up 78% of its $401M portfolio in Q1 2024.
- Bleichroeder LP opened 5 new positions and closed 2 in Q1 2024.
- Bleichroeder LP's portfolio value fell 11% quarter-over-quarter to $401M.
Based on Bleichroeder LP's 13F filing for Q1 2024, filed 14 May 2024.